Upgrade to SI Premium - Free Trial

Sanofi drug gets EU panel backing for progressive multiple sclerosis

April 24, 2026 6:10 AM
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Sanofi's (EURONEXT: SAN) (NASDAQ: SNY) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA